Intensified rifampicin boosts outcomes in TB/HIV coinfection

DURBAN, SOUTH AFRICA – Prescribing high-dose rifampicin in addition to antiretroviral therapy reduces 12-month all-cause mortality in patients who are coinfected with tuberculosis and HIV and who...
Source: Family Practice News - Category: Primary Care Source Type: news